Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Wattanathorn, Jintanaporn ^a   Sriraksa, Napatr ^a   Muchimapura, Supaporn ^a   Tiamkao, Somsak ^a   Brown, Kamoltip ^a   Chaisiwamongkol, Kowit ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OXIDOPAMINE; QUERCETIN; SCAVENGER; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL SURVIVAL; COGNITION; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; MAZE TEST; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; SUBSTANTIA NIGRA;

EID: 80052689560     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/823206     Document Type: Article

References (65)

1. Halliwell B., Reactive oxygen species and the central nervous system Journal of Neurochemistry 1992 59 5 1609 1623
2. Jenner P., Dexter D. T., Sian J., Schapira A. H. V., Marsden C. D., Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease Annals of Neurology 1992 32 supplement S82 S87
3. Yoshikawa T., Free radicals and their scavengers in Parkinson's disease European Neurology 1993 33 1 60 68 (Pubitemid 23235378)
4. Olanow C. W., Tatton W. G., Etiology and pathogenesis of Parkinson's disease Annual Review of Neuroscience 1999 22 123 144 (Pubitemid 29144883)
5. Jenner P., Oxidative stress in Parkinson's disease Annals of Neurology 2003 53 supplement 3 S26 S38 (Pubitemid 36368560)
6. Chaudhuri K. R., Healy D. G., Schapira A. H. V., Non-motor symptoms of Parkinson's disease: diagnosis and management Lancet Neurology 2006 5 3 235 245 (Pubitemid 43238347)
7. Schrag A., Jahanshahi M., Quinn N., What contributes to quality of life in patients with Parkinson's disease? Journal of Neurology Neurosurgery and Psychiatry 2000 69 3 308 312 (Pubitemid 30636233)
8. Martnez-Martn P., Impact of the cognitive impairment on the quality of life in patients with Parkinson's disease Revista de Neurologia 2006 43 3 168 172
9. Findley L., Aujla M., Bain P. G., Baker M., Beech C., Bowman C., Holmes J., Kingdom W. K., MacMahon D. G., Peto V., Playfer J. R., Direct economic impact of Parkinson's disease: a research survey in the United Kingdom Movement Disorders 2003 18 10 1139 1145 (Pubitemid 37336937)
10. Tadaiesky M. T., Dombrowski P. A., Figueiredo C. P., Cargnin-Ferreira E., Da Cunha C., Takahashi R. N., Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease Neuroscience 2008 156 4 830 840
11. Laakso M. P., Partanen K., Riekkinen P., Lehtovirta M., Helkala E. L., Hallikainen M., Hnninen T., Vainio P., Soininen H., Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study Neurology 1996 46 3 678 681 (Pubitemid 26099632)
12. Riekkinen P. Jr., Kejonen K., Laakso M. P., Soininen H., Partanen K., Riekkinen M., Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson's disease patients NeuroReport 1998 9 7 1507 1511 (Pubitemid 28264279)
13. Camicioli R., Moore M. M., Kinney A., Corbridge E., Glassberg K., Kaye J. A., Parkinson's disease is associated with hippocampal atrophy Movement Disorders 2003 18 7 784 790 (Pubitemid 36939973)
14. Takahama U., Scavenging of active oxygen by flavonoids Tanpakushitsu Kakusan Koso 1988 33 16 2994 2999
15. Rogerio A. P., Kanashiro A., Fontanari C., Da Silva E. V. G., Lucisano-Valim Y. M., Soares E. G., Faccioli L. H., Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma Inflammation Research 2007 56 10 402 408 (Pubitemid 350160416)
16. Lamson D. W., Brignall M. S., Antioxidants and cancer III: quercetin Alternative Medicine Review 2000 5 3 196 208 (Pubitemid 30419042)
17. Youdim K. A., Qaiser M. Z., Begley D. J., Rice-Evans C. A., Abbott N. J., Flavonoid permeability across an in situ model of the blood-brain barrier Free Radical Biology and Medicine 2004 36 5 592 604 (Pubitemid 38230176)
18. Cho J. Y., Kim I. S., Jang Y. H., Kim A. R., Lee S. R., Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia Neuroscience Letters 2006 404 3 330 335
19. Heo H. J., Lee C. Y., Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration Journal of Agricultural and Food Chemistry 2004 52 25 7514 7517
20. Mahesh T., Menon V. P., Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats Phytotherapy Research 2004 18 2 123 127 (Pubitemid 38380605)
21. Fiorani M., De Sanctis R., Menghinello P., Cucchiarini L., Cellini B., Dacha M., Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells Free Radical Research 2001 34 6 639 648 (Pubitemid 32694652)
22. Kim M. S., Lee J. I., Lee W. Y., Kim S. E., Neuroprotective effect of Ginkgo biloba L. extract in a rat model of parkinson's disease Phytotherapy Research 2004 18 8 663 666
23. Pu F., Mishima K., Irie K., Motohashi K., Tanaka Y., Orito K., Egawa T., Kitamura Y., Egashira N., Iwasaki K., Fujiwara M., Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats Journal of Pharmacological Sciences 2007 104 4 329 334 (Pubitemid 47378420)
24. Ferro M. M., Bellissimo M. I., Anselmo-Franci J. A., Angellucci M. E. M., Canteras N. S., Da Cunha C., Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations Journal of Neuroscience Methods 2005 148 1 78 87 (Pubitemid 41423461)
25. Morris R. G. M., Spatial localization does not require the presence of local cues Learning and Motivation 1981 12 2 239 260
26. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Analytical Biochemistry 1979 95 2 351 358 (Pubitemid 9194347)
27. Ellman G. L., Courtney K. D., Andres V. Jr., Featherstone R. M., A new and rapid colorimetric determination of acetylcholinesterase activity Biochemical Pharmacology 1961 7 2 88 95
28. McCord J. M., Fridovich I., Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) Journal of Biological Chemistry 1969 244 22 6049 6055
29. Wendel A., Jakoby W. B., Glutathione peroxidase Enzymatic Basis of Detoxification 1980 New York, NY, USA Academic Press
30. Goldblith S. A., Proctor B. E., Photometric determination of catalase activity The Journal of biological chemistry 1950 187 2 705 709
31. Cohen G., Heikkila R. E., Allis B., Destruction of sympathetic nerve terminals by 6 hydroxydopamine: Protection by 1 phenyl 3 (2 thiazolyl) 2 thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n butanol Journal of Pharmacology and Experimental Therapeutics 1976 199 2 336 352
32. Kumar R., Agarwal A. K., Seth P. K., Free radical-generated neurotoxicity of 6-hydroxydopamine Journal of Neurochemistry 1995 64 4 1703 1707
33. Soto-Otero R., Méndez-lvarez E., Hermida-Ameijeiras., Muoz-Patio A. M., Labandeira-Garcia J. L., Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease Journal of Neurochemistry 2000 74 4 1605 1612 (Pubitemid 30163982)
34. Glinka Y. Y., Youdim M. B. H., Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine European Journal of Pharmacology 1995 292 3 329 332
35. Mura A., Feldon J., Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system Movement Disorders 2003 18 8 860 871 (Pubitemid 37021160)
36. Hefco V., Yamada K., Hefco A., Hritcu L., Tiron A., Nabeshima T., Role of the mesotelencephalic dopamine system in learning and memory processes in the rat European Journal of Pharmacology 2003 475 13 55 60 (Pubitemid 37088006)
37. Herndi I., Kardi Z., Vgh J., Petyk Z., Egyed R., Berta B., Lénrd L., Alterations of conditioned taste aversion after microiontophoretically applied neurotoxins in the medial prefrontal cortex of the rat Brain Research Bulletin 2000 53 6 751 758 (Pubitemid 32120279)
38. Florio T., Capozzo A., Nisini A., Lupi A., Scarnati E., Dopamine denervation of specific striatal subregions differentially affects preparation and execution of a delayed response task in the rat Behavioural Brain Research 1999 104 1-2 51 62 (Pubitemid 29421633)
39. De Leonibus E., Pascucci T., Lopez S., Oliverio A., Amalric M., Mele A., Spatial deficits in a mouse model of Parkinson disease Psychopharmacology 2007 194 4 517 525 (Pubitemid 47492993)
40. Fukui K., Omoi N. O., Hayasaka T., Shinnkai T., Suzuki S., Abe K., Urano S., Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E Annals of the New York Academy of Sciences 2002 959 275 284 (Pubitemid 34457568)
41. Good M., Spatial memory and hippocampal function: where are we now? Psicologica 2002 23 1 109 138
42. Winnicka M. M., Wisniewski K., Bilateral 6-OHDA lesions to the hippocampus attenuate the facilitatory effect of CCK-8US and caerulein on memory in rats Pharmacological Research 2000 41 3 347 353 (Pubitemid 30663140)
43. D'Hooge R., De Deyn P. P., Applications of the Morris water maze in the study of learning and memory Brain Research Reviews 2001 36 1 60 90 (Pubitemid 32763130)
44. Perry E. K., Curtis M., Dick D. J., Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease Journal of Neurology Neurosurgery and Psychiatry 1985 48 5 413 421 (Pubitemid 15064881)
45. Drachman D. A., Leavitt J., Human memory and the cholinergic system. A relationship to aging? Archives of Neurology 1974 30 2 113 121
46. Korczyn A. D., Dementia in Parkinson's disease Journal of Neurology, Supplement 2001 248 3 1 4 (Pubitemid 32972395)
47. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C. D., Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease Journal of Neurochemistry 1989 52 2 381 389 (Pubitemid 19037600)
48. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P., Marsden C. D., Increased levels of lipid hydroperoxides in the Parkinsonian Substantia nigra: an HPLC and ESR study Movement Disorders 1994 9 1 92 97 (Pubitemid 24022621)
49. Kish S. J., Morito C., Hornykiewicz O., Glutathione peroxidase activity in Parkinson's disease brain Neuroscience Letters 1985 58 3 343 346 (Pubitemid 15230680)
50. Swanson L. W., The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat Brain Research Bulletin 1982 9 16 321 353 (Pubitemid 13225278)
51. Walaas L., Emson P. C., The hippocampu Chemical Neuroanatomy 1983 New York, NY, USA Raven Press
52. Martins R. D. P., Braga H. D. C., da Silva A. P., Dalmarco J. B., de Bem A. F., dos Santos A. R. S., Dafre A. L., Pizzolatti M. G., Latini A., Aschner M., Farina M., Synergistic neurotoxicity induced by methylmercury and quercetin in mice Food and Chemical Toxicology 2009 47 3 645 649
53. Graf B. A., Ameho C., Dolnikowski G. G., Milbury P. E., Chen C. Y., Blumberg J. B., Rat gastrointestinal tissues metabolize quercetin Journal of Nutrition 2006 136 1 39 44 (Pubitemid 43156482)
54. Mandal S., Hazra B., Sarkar R., Biswas S., Mandal N., Assessment of the antioxidant and reactive oxygen species scavenging activity of methanolic extract of Caesalpinia crista leaf Evidence-Based Complementary and Alternative Medicine 2011 2011 11
55. Waksman De Torres N., Salazar-Aranda R., Pérez-Lpez L. A., Lpez-Arroyo J., Alans-Garza B. A., Antimicrobial and antioxidant activities of plants from northeast of Mexico Evidence-Based Complementary and Alternative Medicine 2011 2011 6
56. Gibellini L., Pinti M., Nasi M., Quercetin and cancer chemoprevention Evidence-Based Complementary and Alternative Medicine 2011 2011 15
57. Heijnen C. G. M., Haenen G. R. M. M., Van Acker F. A. A., Van Der Vijgh W. J. F., Bast A., Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups Toxicology in Vitro 2001 15 1 3 6 (Pubitemid 32226368)
58. Naidu P. S., Singh A., Kulkarni S. K., Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin Pharmacology 2004 70 2 59 67 (Pubitemid 38032498)
59. Afanas'ev I. B., Dorozhko A. I., Brodskii A. V., Kostyuk V. A., Potapovitch A. I., Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation Biochemical Pharmacology 1989 38 11 1763 1769 (Pubitemid 19138525)
60. Da Silva E. L., Piskula M. K., Yamamoto N., Moon J. H., Terao J., Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma FEBS Letters 1998 430 3 405 408 (Pubitemid 28337954)
61. Nagata H., Takekoshi S., Takagi T., Honma T., Watanabe K., Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase Tokai Journal of Experimental and Clinical Medicine 1999 24 1 1 11 (Pubitemid 29403853)
62. Erden Inal M., Kahraman A., Kken T., Beneficial effects of quercetin on oxidative stress induced by ultraviolet A Clinical and Experimental Dermatology 2001 26 6 536 539 (Pubitemid 32955469)
63. Aherne S. A., O'Brien N. M., Protection by the flavonoids myricetin, quercetin, and rutin against hydrogen peroxide-induced DNA damage in Caco-2 and Hep G2 cells Nutrition and Cancer 1999 34 2 160 166 (Pubitemid 29511113)
64. Sanderson J., McLauchlan W. R., Williamson G., Quercetin inhibits hydrogen peroxide-induced oxidation of the rat lens Free Radical Biology and Medicine 1999 26 5-6 639 645 (Pubitemid 29146266)
65. Choi E. J., Chee K. M., Lee B. H., Anti- and prooxidant effects of chronic quercetin administration in rats European Journal of Pharmacology 2003 482 13 281 285 (Pubitemid 37505954)